Watchlist Price Alert

Altamira Therapeutics Ltd... (CYTO)

NASDAQ: CYTO · Real-Time Price · USD

0.30

0.00 (0.00%)

At close: Jan 16, 2025, 9:00 PM

Altamira Therapeutics Income Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	305.62K	63.88K	174.47K	-56K	1.27M	322K	-414K
Cost of Revenue	n/a	1.44M	2.24M	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	-1.14M	-2.18M	174.47K	-56K	1.27M	322K	-414K
Operating Income	-5.92M	-26.13M	-17.1M	-5.28M	-7.26M	-10.95M	-24.36M	-30.22M
Interest Income	730.2K	969.00	3.22K	258.00	17.88K	n/a	53.57K	67.56K
Pretax Income	-7.27M	-26.54M	-17.37M	-8.22M	-6.83M	-11.33M	-24.43M	-30.79M
Net Income	-7.27M	-26.53M	-17.39M	-8.2M	-6.63M	-11.5M	-24.41M	-30.66M
Selling & General & Admin	3.12M	5.9M	6.39M	2.59M	3.93M	4.26M	5.15M	5.41M
Research & Development	3.04M	19.68M	8.94M	2.86M	3.33M	6.69M	19.21M	24.78M
Other Expenses	n/a	-586.73K	-409.93K	n/a	n/a	215.72K	87.59K	34.05K
Operating Expenses	6.54M	24.99M	14.92M	5.46M	7.26M	10.95M	24.36M	30.22M
Interest Expense	n/a	911.87K	189.69K	135.15K	28.63K	1.07M	1.64M	828.55K
Selling & Marketing Expenses	15.35K	2.38M	1.5M	95.66K	113.96K	43.82K	199.48K	45.65K
Cost & Expenses	6.54M	26.44M	17.16M	5.46M	7.26M	10.95M	24.36M	30.22M
Income Tax Expense	n/a	-10.33K	21.62K	-21.28K	-193.84K	162.18K	-17.77K	-131.06K
Shares Outstanding (Basic)	491K	45.54K	33.12K	15.04K	14.54K	3.98K	1.09K	858.20
Shares Outstanding (Diluted)	491.26K	45.54K	33.12K	15.04K	14.54K	3.98K	1.09K	858.20
EPS (Basic)	-14.81	-582.58	-525.13	-545.41	-455.96	-2.89K	-22.32K	-35.73K
EPS (Diluted)	-14.8	-582.58	-525.13	-545.41	-455.96	-2.89K	-22.32K	-35.73K
EBITDA	-1.35M	-17.64M	-6.72M	-5.26M	-7.24M	-10.95M	-24.31M	-30.06M
EBIT	n/a	-17.76M	-6.79M	-8.09M	-6.8M	-10.26M	-22.79M	-29.96M
Depreciation & Amortization	5.92M	118.89K	76.36K	20.04K	30.82K	72.71K	122.78K	97.6K